0903 GMT - Allianz Health is a growth engine within the German insurer, Keefe, Bruyette & Woods says in a research note. The unit includes the non-life and life divisions for external reporting purposes but is a clearer third silo internally. It has historically delivered double-digit operating profit growth, which it seems management hopes to maintain, analyst William Hawkins writes. The division has the potential for structural growth, the analyst says. It has seen margin improvement in its core European markets and growth in mostly Asian developing economies, which the insurer has flagged as markets with high growth potential, he notes. Shares trade at 344.2 euros and have risen 16% since the start of the year. (elena.vardon@wsj.com)
(END) Dow Jones Newswires
June 30, 2025 05:03 ET (09:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。